Filtered By:
Drug: Rituxan
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 7090 results found since Jan 2013.
Seronegative necrotizing autoimmune myopathy with favorable response to intravenous immunoglobulin
We describe a 68-year-old man who presented with progressive weakness in proximal muscles of all four limbs and was found to have autoantibody-negative necrotizing autoimmune myopathy (NAM). His myopathy was refractory to corticosteroids and methotrexate, but subsequently demonstrated successful response to intravenous immunoglobulin (IVIG). The patient also received rituximab, but the timing of his recovery favored IVIG as the more important factor in terms of efficacy. Treatment guidelines for seronegative necrotizing myopathies are lacking. This case suggests a potential efficacious treatment option for the seronegative...
Source: Baylor University Medical Center Proceedings - July 5, 2021 Category: Universities & Medical Training Authors: Rebecca Liu Andrew Z Fenves Samantha N Champion Jonathan Dau Source Type: research
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
CONCLUSION: In the last decade, the outcome of newly diagnosed MCL patients improved. ASCT in the first remission was the main contributor in transplantable patients and BR in non-transplantable. Regularly updated national guidelines may help in a timely adoption of new treatments, thus improving the results.PMID:34730885 | PMC:PMC8596472 | DOI:10.3325/cmj.2021.62.455-63
Source: Croatian Medical Journal - November 3, 2021 Category: General Medicine Authors: Sandra Ba šić-Kinda Karla Mi šura Jakobac Jasminka Sin čić-Petričević Dajana Deak Marijo Vodanovi ć Marinka Jaki ć-Bubalo Zdravko Mitrovi ć Aron Grube šić Barbara Dreta Dubravka Županić Krmek Bo žena Coha Delfa Radi ć-Krišto Igor Aurer Source Type: research
